[{"notes_id":"1_2424","category":"1","subcategory":"1","title":"Atrial fibrillation: a very basic introduction","body":"Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia. It is very common, being present in around 5% of patients over aged 70-75 years and 10% of patients aged 80-85 years. Whilst uncontrolled atrial fibrillation can result in symptomatic palpitations and inefficient cardiac function probably the most important aspect of managing patients with AF is reducing the increased risk of stroke which is present in these patients.<br \/><br \/><br \/><h5 class='notes-heading'>Types of atrial fibrillation<\/h5><br \/>AF may by classified as either first detected episode, paroxysmal, persistent or permanent.<br \/><ul><li><span class=\"concept\" data-cid=\"7653\">first detected episode<\/span> (irrespective of whether it is symptomatic or self-terminating)<\/li><li>recurrent episodes, when a patient has 2 or more episodes of AF. If episodes of AF terminate spontaneously then the term <b><span class=\"concept\" data-cid=\"7654\">paroxysmal AF<\/span><\/b> is used. Such episodes last less than 7 days (typically < 24 hours). If the arrhythmia is not self-terminating then the term <b><span class=\"concept\" data-cid=\"7655\">persistent AF<\/span><\/b> is used. Such episodes usually last greater than 7 days<\/li><li>in <b><span class=\"concept\" data-cid=\"7656\">permanent AF<\/span><\/b> there is continuous atrial fibrillation which cannot be cardioverted or if attempts to do so are deemed inappropriate. Treatment goals are therefore rated control and anticoagulation if appropriate<\/li><\/ul><br \/><br \/><h5 class='notes-heading'>Symptoms and signs<\/h5><br \/>Symptoms<br \/><ul><li>palpitations<\/li><li>dyspnoea<\/li><li>chest pain<\/li><\/ul><br \/>Signs<br \/><ul><li>an irregularly irregular pulse<\/li><\/ul><br \/><br \/><h5 class='notes-heading'>Investigations<\/h5><br \/>An ECG is essential to make the diagnosis as other conditions can give an irregular pulse, such as ventricular ectopics or sinus arrhythmia.<br \/><br \/><div class=\"container\"><div class=\"row\"><div class=\"col-md-3\"><a href=\"https:\/\/d32xxyeh8kfs8k.cloudfront.net\/images_Passmedicine\/ecg097b.png\" data-fancybox=\"gallery\" data-caption=\"Atrial fibrillation - e Image used on license from Dr Smith, University of Minnesota\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https:\/\/d32xxyeh8kfs8k.cloudfront.net\/images_Passmedicine\/ecg097.png\" alt=\"\" \/><\/a><\/div><\/div><\/div><br \/><h5 class='notes-heading'>Management<\/h5><br \/>There are two key parts of managing patients with AF:<br \/><ul><li>1. Rate\/rhythm control<\/li><li>2. Reducing stroke risk<\/li><\/ul><br \/><h5 class='notes-heading'>Rate vs. rhythm control<\/h5><br \/>There are two main strategies employed in dealing with the arrhythmia element of atrial fibrillation:<br \/><ul><li><b>rate control<\/b>: accept that the pulse will be irregular, but slow the rate down to avoid negative effects on cardiac function<\/li><li><b>rhythm control<\/b>: try to get the patient back into, and maintain, normal sinus rhythm. This is termed cardioversion. Drugs (pharmacological cardioversion) and synchronised DC electrical shocks (electrical cardioversion) may be used for this purpose<\/li><\/ul><br \/>For many years the predominant approach was to try and maintain a patient in sinus rhythm. This approach changed in the early 2000's and now the majority of patients are managed with a rate control strategy. NICE advocate using a rate control strategy except in a number of specific situations such as <span class=\"concept\" data-cid=\"3120\">coexistent heart failure, first onset AF or where there is an obvious reversible cause<\/span>.<br \/><br \/><h5 class='notes-heading'>Rate control<\/h5><br \/>A <b>beta-blocker<\/b> or a <b>rate-limiting calcium channel blocker<\/b> (e.g. diltiazem) is used first-line to control the rate in AF. <br \/><br \/>If one drug does not control the rate adequately NICE recommend combination therapy with any 2 of the following:<br \/><ul><li>a betablocker<\/li><li>diltiazem<\/li><li>digoxin<\/li><\/ul><br \/><h5 class='notes-heading'>Rhythm control<\/h5><br \/>As mentioned above there are a subgroup of patients for whom a rhythm control strategy should be tried first. Other patients may have had a rate control strategy initially but switch to rhythm control if symptoms\/heart rate fails to settle.<br \/><br \/>When considering cardioversion it is very important to remember that the moment a patient switches from AF to sinus rhythm presents the highest risk for embolism leading to stroke. Imagine the thrombus formed in the fibrillating atrium suddenly being pushed out when sinus rhythm is restored. For this reason patients must either have had a short duration of symptoms (less than 48 hours) or be anticoagulated for a period of time prior to attempting cardioversion.<br \/><br \/><br \/><h5 class='notes-heading'>Reducing stroke risk<\/h5><br \/>Some patients with AF are at a very low risk of stroke whilst others are at a very significant risk. Clinicians use risk stratifying tools such as the <b>CHA<sub>2<\/sub>DS<sub>2<\/sub>-VASc<\/b> score to determine the most appropriate anticoagulation strategy. <br \/><br \/><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th><\/th><th><b>Risk factor<\/b><\/th><th><b>     Points<\/b><\/th><\/tr><\/thead><tbody><tr><td> <b>C<\/b><\/td><td>Congestive heart failure<\/td><td>1<\/td><\/tr><tr><td> <b>H<\/b><\/td><td>Hypertension (or treated hypertension)<\/td><td>1<\/td><\/tr><tr><td> <b>A<sub>2<\/sub><\/b><\/td><td>Age >= 75 years<\/td><td>2<\/td><\/tr><tr><td><\/td><td>Age 65-74 years<\/td><td>1<\/td><\/tr><tr><td> <b>D<\/b><\/td><td>Diabetes<\/td><td>1<\/td><\/tr><tr><td> <b>S<sub>2<\/sub><\/b><\/td><td>Prior Stroke, TIA or thromboembolism<\/td><td>2<\/td><\/tr><tr><td> <b>V<\/b><\/td><td>Vascular disease (including ischaemic heart disease and peripheral arterial disease)<\/td><td>1<\/td><\/tr><tr><td><b>S<\/b><\/td><td>Sex (female)<\/td><td>1<\/td><\/tr><\/tbody><\/table><\/div><br \/>The table below shows a suggested anticoagulation strategy based on the score:<br \/><br \/><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid2\" ><thead><tr><th><b>Score<\/b><\/th><th><b>Anticoagulation<\/b><\/th><\/tr><\/thead><tbody><tr><td>0<\/td><td><span class=\"concept\" data-cid=\"7649\">No treatment<\/span><\/td><\/tr><tr><td>1<\/td><td><span class=\"concept\" data-cid=\"7650\">Males: Consider anticoagulation<\/span><br \/><span class=\"concept\" data-cid=\"7651\">Females: No treatment (this is because their score of 1 is only reached due to their gender)<\/span><\/td><\/tr><tr><td>2 or more<\/td><td><span class=\"concept\" data-cid=\"7652\">Offer anticoagulation<\/span><\/td><\/tr><\/tbody><\/table><\/div><br \/>NICE recommend that we offer patients a choice of anticoagulation, including warfarin and the novel oral anticoagulants (NOACs).","notes_hash":"8fd7cfbec4f5d238e2073f82f1b488f7","knowledge_graph_node_id_link":1162,"links":"<table style='width:100%'><tr><td>NICE<\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_2043\" data-linkid=\"2043\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"link_good_count_2043\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">24<\/span><button type=\"button\" style=\"\" id=\"link_dislike_2043\" data-linkid=\"2043\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"link_bad_count_2043\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">14<\/span><\/td><\/tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https:\/\/www.nice.org.uk\/guidance\/ng196\/chapter\/Recommendations\">2021 Atrial fibrillation guidelines<\/a><\/td><\/tr><\/table>","media":"<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https:\/\/upload.wikimedia.org\/wikipedia\/commons\/6\/61\/Atrial_fibrillation_video.webm\" data-description=\"Atrial fibrillation\" data-upvotes=\"3\" data-downvotes=\"0\" data-media=\"99\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https:\/\/d32xxyeh8kfs8k.cloudfront.net\/css\/images\/osmosis.png\" style=\"max-width:150px;\"><\/a><\/td><\/tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https:\/\/upload.wikimedia.org\/wikipedia\/commons\/6\/61\/Atrial_fibrillation_video.webm\" data-description=\"Atrial fibrillation\" data-upvotes=\"3\" data-downvotes=\"0\" data-media=\"99\">Atrial fibrillation<\/a><\/td><\/tr><tr><td><span ><small>Osmosis - YouTube<\/small><\/span><\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_168\" data-mediaid=\"168\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"media_good_count_168\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">3<\/span><button type=\"button\" style=\"\" id=\"media_dislike_168\" data-mediaid=\"168\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"media_bad_count_168\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0<\/span><\/td><\/tr><tr><td>&nbsp;<\/td><\/tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/wxJuP-i9Jx0\" data-description=\"Atrial Fibrillation Overview - ECG, types, pathophysiology, treatment, complications\" data-upvotes=\"1\" data-downvotes=\"0\" data-media=\"1107\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https:\/\/i1.ytimg.com\/vi\/wxJuP-i9Jx0\/mqdefault.jpg\" style=\"max-width:150px;\"><\/a><\/td><\/tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/wxJuP-i9Jx0\" data-description=\"Atrial Fibrillation Overview - ECG, types, pathophysiology, treatment, complications\" data-upvotes=\"1\" data-downvotes=\"0\" data-media=\"1107\">Atrial Fibrillation Overview - ECG, types, pathophysiology, treatment, complications<\/a><\/td><\/tr><tr><td><span ><small>Armando Hasudungan - YouTube<\/small><\/span><\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1912\" data-mediaid=\"1912\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"media_good_count_1912\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">1<\/span><button type=\"button\" style=\"\" id=\"media_dislike_1912\" data-mediaid=\"1912\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"media_bad_count_1912\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0<\/span><\/td><\/tr><tr><td>&nbsp;<\/td><\/tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/J33lfh6w3gI\" data-description=\"Understanding Atrial Fibrillation\" data-upvotes=\"0\" data-downvotes=\"0\" data-media=\"1688\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https:\/\/i1.ytimg.com\/vi\/J33lfh6w3gI\/mqdefault.jpg\" style=\"max-width:150px;\"><\/a><\/td><\/tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/J33lfh6w3gI\" data-description=\"Understanding Atrial Fibrillation\" data-upvotes=\"0\" data-downvotes=\"0\" data-media=\"1688\">Understanding Atrial Fibrillation<\/a><\/td><\/tr><tr><td><span ><small>Zero To Finals - YouTube<\/small><\/span><\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2864\" data-mediaid=\"2864\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"media_good_count_2864\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">0<\/span><button type=\"button\" style=\"\" id=\"media_dislike_2864\" data-mediaid=\"2864\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"media_bad_count_2864\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0<\/span><\/td><\/tr><tr><td>&nbsp;<\/td><\/tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/99GHi5UxU6c\" data-description=\"Atrial Fibrillation Made Easy\" data-upvotes=\"4\" data-downvotes=\"1\" data-media=\"1378\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https:\/\/i1.ytimg.com\/vi\/99GHi5UxU6c\/mqdefault.jpg\" style=\"max-width:150px;\"><\/a><\/td><\/tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/99GHi5UxU6c\" data-description=\"Atrial Fibrillation Made Easy\" data-upvotes=\"4\" data-downvotes=\"1\" data-media=\"1378\">Atrial Fibrillation Made Easy<\/a><\/td><\/tr><tr><td><span ><small>Rhesus Medicine - YouTube<\/small><\/span><\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2426\" data-mediaid=\"2426\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"media_good_count_2426\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">4<\/span><button type=\"button\" style=\"\" id=\"media_dislike_2426\" data-mediaid=\"2426\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"media_bad_count_2426\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1<\/span><\/td><\/tr><\/table>","concepts_for_notes":{"7649":{"concept_text":"CHA2DS2-VASc of 0 - no anticoagulation","concept_percentile":"26"},"7650":{"concept_text":"CHA2DS2-VASc of 1 (male) - consider (rather than offer) anticoagulation with warfarin or new oral anticoagulants (NOACs)","concept_percentile":"42"},"7651":{"concept_text":"CHA2DS2-VASc of 1 (female) - no anticoagulation","concept_percentile":"63"},"7652":{"concept_text":"CHA2DS2-VASc of 2 or more - offer (rather than consider) anticoagulation with warfarin or new oral anticoagulants (NOACs)","concept_percentile":"29"},"7653":{"concept_text":"A 50-year-old man with no history of arrhythmia develops atrial fibrillation whilst being treated for pneumonia in hospital - first time atrial fibrillation","concept_percentile":"39"},"7654":{"concept_text":"A 60-year-old man is found to have recurrent episodes of atrial fibrillation than terminate sponatenously after 1-2 days - paroxysmal atrial fibrillation","concept_percentile":"32"},"7655":{"concept_text":"A 60-year-old man has recurrent episodes of atrial fibrillation which don't self terminate. He uses flecanide to cardiovert himself into sinus rhythm - persistent atrial fibrillation","concept_percentile":"43"},"7656":{"concept_text":"A 70-year-old man is treated with a beta-blocker to control his atrial fibrillation. A previous attempt to cardiovert him failed - permanent atrial fibrillation","concept_percentile":"31"}},"category_name":"Cardiovascular","subcategory_name":"Cardiology","comment_count":7},"",[]]